News Briefs
America’s National Cancer Institute (NCI) has acknowledged oleocanthal as a potential nutraceutical for breast cancer and awarded $399,999 to the company, Oleolive, for the development of the phenolic compound as a functional food to prevent breast cancer.
The funds will be used to research the preventative and therapeutic benefits of oleocanthal in triple negative breast cancer (TNBC) recurrence. Around 50,000 women in the United States are diagnosed with TNBC annually.
See Also:Health NewsA new, safe and effective recurrence inhibitor is urgently needed as the current outlook for TNBC patients is bleak due to high recurrence rates, poor overall survival rates and ineffective available treatments.
Oleocanthal experts Khalid El Sayed and Amal Kaddoumi, who are the company’s chief scientists and researchers at the University of Louisiana-Monroe, co-authored a 2017 study which revealed that oleocanthal was effective in preventing cancer and Alzheimer’s disease in mice and had the potential to become an effective dietary supplement for reducing the risk of developing both conditions.
El Sayed told Olive Oil Times the nutraceutical will be made available to patients once the team has established the desired potency and efficacy of the oleocanthal formulation for preventing TNBC recurrence. He said that further funding would be sought to prepare the formulation for clinical trials on humans.
“[I would] certainly recommend consumption of high-quality extra virgin olive oil daily for not only breast cancer survivors and patients but also for normal healthy people to maintain a condition of well-being based on the significant positive health outcomes documented by several clinical trials and epidemiological studies,” he said.
His recommendation was an average daily consumption of around 20 to 50 milliliters of olive oil per day, depending on an individual’s health and the quality of olive oil consumed. He advised new consumers of olive oil to start with smaller amounts (five to 10 milliliters) and gradually increase the daily dose over time.
More articles on: breast cancer, cancer prevention, oleocanthal
Aug. 18, 2023
Biophenols in EVOO Linked to Improved Outcomes in Obesity and Prediabetes
Research finds that consuming extra virgin olive oil rich in oleocanthal and oleacein also induces weight loss, a decrease in body mass index and basal glycemia.
Jul. 25, 2023
Patients Respond to Nutrition Guidance Via Telehealth, Study Shows
Intervention through telehealth can positively complement face-to-face care in sustaining dietary and lifestyle changes.
Jul. 19, 2023
Researchers in California Test New Solutions for Olive Fruit Fly
Researchers at the University of California are testing a range of insecticide products for efficacy in controlling olive fruit flies.
Jul. 26, 2023
Mediterranean Diet Associated with Successful Aging, Study Finds
Researchers found that Greeks who followed the Mediterranean diet were healthier and more active as they aged than those who followed the diet less closely.
Apr. 9, 2024
The Role of Monounsaturated Fatty Acids in Olive Oil's Health Benefits
Oleic acid, classified as a monounsaturated fatty acid (MUFA), has been extensively studied by scientists over the last decades, consistently demonstrating many positive effects on human health.
Jan. 2, 2024
Study Reveals How Polyphenols Lower Insulin Resistance
Mice fed a high-fat diet comprised of polyphenol-enriched extra virgin olive oil demonstrated gene expressions associated with reduced oxidative stress and inflammation.
Jan. 3, 2024
Promoting the Role of Women in the Olive Sector
Jill Myers founded the Women in Olive Oil network to connect women across the sector while promoting their voices and highlighting their contributions.
Dec. 4, 2023
How the Iberian Ant Can Help Control Pests in Olive Groves
Researchers found that Iberian ants naturally prey on olive moth larvae in olive groves without disrupting the rest of the ecosystem.